01 2MSN Laboratories Private Limited
02 2Olon S.p.A.
03 1Shanghai SynTheAll Pharmaceutical Co., Ltd.
04 1Siegfried AG
05 1Siegfried Evionnaz SA
01 1ZANUBRUTINIB
02 3Zanubrutinib
03 1Zanubrutinib (Form-A)
04 1Zanubrutinib Amorphous
05 1Zanubrutinib Amorphous Milled
01 1China
02 2India
03 2Italy
04 2Switzerland
NDC Package Code : 54893-0502
Start Marketing Date : 2023-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0510
Start Marketing Date : 2024-03-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0321
Start Marketing Date : 2023-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0322
Start Marketing Date : 2023-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17205-628
Start Marketing Date : 2023-06-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 17381-929
Start Marketing Date : 2019-10-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 24538-311
Start Marketing Date : 2019-11-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
48
PharmaCompass offers a list of Zanubrutinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zanubrutinib manufacturer or Zanubrutinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zanubrutinib manufacturer or Zanubrutinib supplier.
PharmaCompass also assists you with knowing the Zanubrutinib API Price utilized in the formulation of products. Zanubrutinib API Price is not always fixed or binding as the Zanubrutinib Price is obtained through a variety of data sources. The Zanubrutinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zanubrutinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zanubrutinib, including repackagers and relabelers. The FDA regulates Zanubrutinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zanubrutinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zanubrutinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zanubrutinib supplier is an individual or a company that provides Zanubrutinib active pharmaceutical ingredient (API) or Zanubrutinib finished formulations upon request. The Zanubrutinib suppliers may include Zanubrutinib API manufacturers, exporters, distributors and traders.
click here to find a list of Zanubrutinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zanubrutinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zanubrutinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zanubrutinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zanubrutinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zanubrutinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zanubrutinib suppliers with NDC on PharmaCompass.
We have 4 companies offering Zanubrutinib
Get in contact with the supplier of your choice:
